CD99 and breast carcinoma: In human breast cancer, expression of the splice variant of CD99 increased the activity and expression of MMP-9 and contributed to the invasive phenotype by upregulating AP1-mediated gene expression through the AKT-dependent, ERK, and JNK signaling pathways [21].